Lutein nanocrystals as antioxidant formulation for oral and dermal delivery

International Journal of Pharmaceutics

Volumn 420, Issue 1, 2011, Pages 141-146

  Mitri, Khalil ^a,b   Shegokar, Ranjita ^a   Gohla, Sven ^c   Anselmi, Cecilia ^b   Müller, Rainer H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF SIENA   (Italy)

^c Research and Development of the la Prairie Group   (Switzerland)

Author keywords

Antioxidant; Dermal penetration; Dissolution velocity; Lutein; Nanosuspension; Saturation solubility

Indexed keywords

PYROXYLIN; XANTHOPHYLL;

ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; FEASIBILITY STUDY; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; STORAGE TEMPERATURE; SUSPENSION; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; COLLODION; DRUG STABILITY; GELS; KINETICS; LUTEIN; MEMBRANES, ARTIFICIAL; NANOPARTICLES; NANOTECHNOLOGY; OINTMENTS; PARTICLE SIZE; PERMEABILITY; PHOTOELECTRON SPECTROSCOPY; POWDERS; SKIN; SKIN ABSORPTION; SOLUBILITY; SURFACE-ACTIVE AGENTS; SWINE; TECHNOLOGY, PHARMACEUTICAL;

EID: 80054683938     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.08.026     Document Type: Article

References (33)

1. L. Al Shaal, R.H. Müller, and R. Shegokar smartCrystal combination technology - scale up from lab to pilot scale and long term stability Pharmazie 65 2010 877 884
2. A. Alves-Rodrigues, and A. Shao The science behind lutein Toxicol. Lett. 150 2004 57 83 (Pubitemid 38447237)
3. K. Asplund Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review J. Intern. Med. 251 2002 372 392 (Pubitemid 34534113)
4. B.J. Aungst Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism J. Pharm. Sci. 82 1993 979 987 (Pubitemid 23314099)
5. H.E. Bartlett, and F. Eperjesi Carotenoids and ocular disease: a review Agro Food Ind. Hi - Tech. 15 2004 19 21 (Pubitemid 40244786)
6. R. Calcinari The zeta potential and its value in pharmaceutical technology Farmaco. Prat. 25 1970 24 38
7. J.T. Carstensen, K.P. Stremming, and P. Pothisiri Sedimentation kinetics of flocculated suspensions. 3. Effect of zeta-potential J. Pharm. Sci. 61 1972 1999 2000
8. J. Chingunpituk Nanosuspension technology for drug delivery Walailak J. Sci. Technol. 4 2007 139 153
9. N. Dayan Skin Aging Handbook - An Integrated Approach to Biochemistry and Product Development 2008 William Andrew Publishing 203-291
10. A.E. Hak, J. Ma, C.B. Powell, H. Campos, J.M. Gaziano, W.C. Willett, and M.J. Stampfer Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke Stroke 35 2004 1584 1588 (Pubitemid 38823629)
11. J.B. Kayes Pharmaceutical suspensions: relation between zeta potential, sedimentation volume and suspension stability J. Pharm. Pharmacol. 29 1977 199 204 (Pubitemid 8079043)
12. C.M. Keck, and R.H. Müller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
13. J.T. Landrum, and R.A. Bone Lutein, zeaxanthin, and the macular pigment Arch. Biochem. Biophys. 385 2001 28 40 (Pubitemid 32988979)
14. A.L. Le Roy Boehm, and H. Fessi Pharmaceutical applications of the zeta potential - use in characterization of colloidal drug carriers J. Pharm. Belg. 55 2000 40 48 (Pubitemid 30265900)
15. E.H. Lee, D. Faulhaber, K.M. Hanson, W. Ding, S. Peters, S. Kodali, and R.D. Granstein Dietary lutein reduces ultraviolet radiation-induced inflammation and immunosuppression J. Invest. Dermatol. 122 2004 510 517 (Pubitemid 38281077)
16. P.H. List, B.W. Müller, and E. Nürnberg Arzneiformenlehre, ein Lehrbuch für Pharmazeuten 3 ed 1982 Wissenschaftliche Verlagsgesellschaft Stuttgart
17. R. Mauludin, R.H. Müller, and C.M. Keck Development of an oral rutin nanocrystal formulation Int. J. Pharm. 370 2009 202 209
18. M. Mishra, R. Shegokar, R.H. Müller, and S. Gohla Glycyrrhetinic acid smartCrystal® with improved skin penetration American Association of Pharmaceutical Scientist (AAPS) Anual Meeting and Exposition Washington DC 2011
19. P.R. Mishra, L. Al Shaal, R.H. Müller, and C.M. Keck Production and characterization of Hesperetin nanosuspensions for dermal delivery Int. J. Pharm. 371 2009 182 189
20. S.M. Moeller, R. Voland, L. Tinker, B.A. Blodi, M.L. Klein, K.M. Gehrs, E.J. Johnson, D.M. Snodderly, R.B. Wallace, R.J. Chappell, N. Parekh, C. Ritenbaugh, and J.A. Mares Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the carotenoids in the age-related eye disease study, an ancillary study of the women's health initiative Arch. Ophthalmol. 126 2008 354 364 (Pubitemid 351398459)
21. R.H. Müller, B.H.L. Bohm, and M.J. Grau Nanosuspensions-formulations for poorly soluble drugs with poor bioavailability/Ist communication: production and properties Pharm. Ind. 61 1999 74
22. R.H. Müller A. Paperback, Zetapotential und Partikeladung in der Laborpraxis Band 37 1996 Wissenschaftliche Verlagsgeselschaft GmbH Stuttgart
23. R.H. Müller, and A. Akkar Drug nanocrystals of poorly soluble drugs H.S. Nalwa, Encyclopedia of Nanoscience and Nanotechnology 2004 American Scientific Publishers 627 638
24. R.H. Müller, C. Jacobs, and O. Kayser Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 2001 3 19 (Pubitemid 32209229)
25. R.H. Müller, and C.M. Keck Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles J. Biotechnol. 113 2004 151 170 (Pubitemid 39237077)
26. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 2002 S131 S155
27. P. Palombo, G. Fabrizi, V. Ruocco, E. Ruocco, J. Fluhr, R. Roberts, and P. Morganti Beneficial long-term effects of combined oral/topical antioxidant treatment with the carotenoids lutein and zeaxanthin on human skin: a double-blind, placebo-controlled study Skin Pharmacol. Physiol. 20 2007 199 210 (Pubitemid 47000424)
28. R.L. Roberts, J. Green, and B. Lewis Lutein and zeaxanthin in eye and skin health Clin. Dermatol. 27 2009 195 201
29. R. Shegokar, and R.H. Müller Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives Int. J. Pharm. 399 2010 129 139
30. J. Shim, H. Seok Kang, W.S. Park, S.H. Han, J. Kim, and I.S. Chang Transdermal delivery of mixnoxidil with block copolymer nanoparticles J. Control. Release 97 2004 477 484 (Pubitemid 38802949)
31. V. Teeranachaideekul, V.B. Junyaprasert, E.B. Souto, and R.H. Müller Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology Int. J. Pharm. 354 2008 227 234
32. S. Verma, R. Gokhale, and D.J. Burgess A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions Int. J. Pharm. 380 2009 216 222
33. A. Wu, M.A. Pathak, M. Sifakis, D.A. Goukassian, and S. Gonzalez Oral administration of lutein modulates cell proliferation induced by acute UVB radiation in the SHK-1 hairless mouse animal model The Society of Investigative Dermatology, 63rd Annual Meeting Los Angeles, CA 2002 Abstract # 769